Quick Search 
Drugs of the Future
Register or sign in

  
 
  
Volume 20, Issue 10, October 1995

MONOGRAPHS

Acetyl-L-Carnitine Hydrochloride. Treatment for diabetic neuropathy. E. Arrigoni-Martelli

BAY-X 1005. Leukotriene synthesis inhibitor. R. Müller-Peddinghaus, S. Raddatz

DMG-DMDOT. Tetracycline antibiotic. R.A. Fromtling, J. Castañer

ML-3000. Antiinflammatory, Cyclooxygenase and 5-lipoxygenase inhibitor. X. Rabasseda, N. Mealy, J. Castañer

PSC-833. Multidrug resistance reversing agent. C. Robinson, J. Castañer

Vamicamide. Anticholinergic, Agent for urinary incontinence. N. Mealy, J. Castañer


REVIEW ARTICLES

Metabolically stable neurotensin mimetics and their possible role as CNS therapeutic agents: David J. Wustrow

Progress in sigma receptor research: Steven D. Wyrick, Raymond G. Booth

Information Update 1-19
Alfuzosin Hydrochloride
Alteplase
Anaritide
Atamestane
BCX-34
Bemesetron
Bisaramil Hydrochloride
Bupropion
Carvedilol
Cefepime
Clarithromycin
Clinafloxacin
Cloricromen
CT-112
DS-4574
Ebselen
Eliprodil Hydrochloride
GM-611
Hind(Rulnd2Cl4)
IMREG-1
Iroloxacin
Ketorolac
KW-3902
L-733560
Lidakol™
Ligustrazine
Lobaplatin
Mafosfamide Cyclohexylamine Salt
Mifepristone
MMU-18006
MX2
Na[trans-RuCl4(DMSO)lm].2DMSO
Nafamostat Mesylate
NB-598
Nebivolol
Neplanocin A
Nevirapine
Nocloprost
OPC-21268
Org-9487
Propagermanium
Quinagolide Hydrochloride
Riluzole
Rimexolone
Saruplase
Satumomab
Sirolimus
Stavudine
Suramin Sodium
Talipexole Dihydrochloride
Tetrandrine


 
  



© 2020 Clarivate Analytics. All rights reserved.
Copyright NoticeTerms of UsePrivacy StatementCookie Policy